Corticotropin-releasing factor (CRF) antagonist suppresses stress-induced locomotor activity in an amphibian.
Intracerebroventricular (icv) injections of corticotropin-releasing factor (CRF; 25 ng) given to male rough-skinned newts (Taricha granulosa) stimulated locomotor activity tested in a circular arena starting 35 min after the injection. The CRF receptor antagonist, alpha-helical CRF9-41 (ahCRF; 250 or 500 ng), injected icv concurrently with CRF blocked CRF-induced locomotor activity. In contrast, icv injection of ahCRF had no effect on spontaneous locomotor activity. Other studies examined the effect of ahCRF on the elevated locomotor activity that was observed when the animals were stressed (handled or placed in warm water). The CRF antagonist dose dependently attenuated the response to either handling or warm stress tested 2 hr after drug treatment. We also examined the effect of the alpha 2-adrenergic agonist, clonidine, on spontaneous and CRF-induced locomotor activity. Clonidine injected icv dose dependently suppressed spontaneous locomotor activity but not CRF-induced locomotor activity. These studies support the hypothesis that endogenous CRF is involved in mediating stress-induced locomotor activity and indicate that the effects of CRF on locomotor activity are independent of activation of the alpha 2-adrenergic system.
Lowry
C A
CA
Department of Zoology, Oregon State University, Corvallis 97331.
Moore
F L
FL
D000818:Animals; D001143:Arousal / Q000502:physiology*; D001833:Body Temperature Regulation / Q000502:physiology; D001921:Brain / Q000502:physiology; D003346:Corticotropin-Releasing Hormone / Q000502:physiology*; D008297:Male; D009043:Motor Activity / Q000502:physiology*; D009474:Neurons / Q000502:physiology; D009638:Norepinephrine / Q000502:physiology; D011941:Receptors, Adrenergic / Q000502:physiology; D012455:Salamandridae / Q000502:physiology*; D012931:Social Environment
D011941:Receptors, Adrenergic; D003346:Corticotropin-Releasing Hormone; D009638:Norepinephrine